What is the link to the European Respiratory Society 2026 guidelines for pulmonary arterial hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ERS 2026 Guidelines for PAH Do Not Exist

There are no European Respiratory Society (ERS) guidelines for pulmonary arterial hypertension published in 2026. The most recent joint ESC/ERS guidelines for pulmonary hypertension were published in 2022, not 2026 1.

Current Guidelines Available

The 2022 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension represent the most up-to-date official guidance 2. These updated the previous 2015 ESC/ERS guidelines and incorporated recommendations from the 6th World Symposium on Pulmonary Hypertension.

Key Changes in the 2022 Guidelines:

  • New hemodynamic definition: Mean pulmonary artery pressure (mPAP) threshold lowered from ≥25 mmHg to >20 mmHg to define PH 2
  • Pulmonary vascular resistance (PVR) threshold of >2 Wood units now required for pre-capillary PH classification 2
  • Reintroduction of exercise-induced PH as a diagnostic entity 2, 3
  • Refined 4-strata risk stratification at follow-up, splitting the intermediate-risk group into intermediate-low and intermediate-high 4
  • Updated treatment algorithms emphasizing upfront combination therapy for most PAH patients 5, 6

Where to Access the Guidelines

The official 2022 ESC/ERS guidelines are published in both the European Heart Journal and the European Respiratory Journal 1. They are freely available on the ESC website at: http://www.escardio.org/Guidelines-&-Education/Clinical-Practice-Guidelines 1.

Important Caveat

If you are looking for the most recent guidance, ensure you are referencing the 2022 guidelines, not searching for non-existent 2026 guidelines. The 7th World Symposium on Pulmonary Hypertension held in Barcelona in June 2024 has provided updated recommendations that may inform future guideline revisions 5, but these have not yet been incorporated into official ESC/ERS guidelines.

Related Questions

Can a tight closure after hernia repair cause pulmonary arterial hypertension (PAH)?
What are the causes of severe pulmonary arterial hypertension?
What are the criteria for a positive response to acute vasoreactive testing in pulmonary arterial hypertension?
What is the definition of hemodynamic, especially regarding a patient with a recent acute pulmonary embolism treated with apixaban?
In a 30-year-old female with one-week facial, chest, and throat pressure, tachycardia, hypertension, no fever, cough, dyspnea, and no risk factors for thrombosis, what urgent evaluation and management is indicated?
What is the appropriate dosing regimen of pregabalin (Lyrica) for neuropathic pain?
What are the recommended dosages of pseudoephedrine and Bromphen DM (brompheniramine/dextromethorphan) for adults and for children?
In a 29‑year‑old woman with high academic achievement who reports pervasive over‑analysis, distractibility, difficulty staying on task, multitasking to the point of constant overwhelm, significant anxiety, frequent interruptions of others, finger‑picking, and inability to sit still that worsened after a recent change in environment, what is the most likely diagnosis and what initial evaluation and management steps are recommended?
Which sleep aid has minimal hepatic metabolism and does not adversely affect liver function?
Can a Daith ear piercing be an effective treatment for migraine?
What is the appropriate initial sertraline dosing for an adult patient who has recently stopped drinking and has impaired renal function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.